0005

Northeast Pharmaceutical Group Co., Ltd. Stock Price

SZSE:000597 Community·CN¥7.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

000597 Share Price Performance

CN¥5.33
0.27 (5.34%)
CN¥5.33
0.27 (5.34%)
Price CN¥5.33

000597 Community Narratives

There are no narratives available yet.

Recent 000597 News & Updates

Northeast Pharmaceutical Group Co., Ltd. Key Details

CN¥7.2b

Revenue

CN¥4.6b

Cost of Revenue

CN¥2.6b

Gross Profit

CN¥2.2b

Other Expenses

CN¥382.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 28, 2025
Earnings per share (EPS)
0.27
Gross Margin
36.07%
Net Profit Margin
5.32%
Debt/Equity Ratio
33.1%

Northeast Pharmaceutical Group Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
2 Rewards

About 000597

Founded
1946
Employees
5964
CEO
Yonggang Cai
WebsiteView website
www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. The company also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and narcotic-containing products, including morphine hydrochloride injection, pethidine hydrochloride injection, morphine hydrochloride tablets, oxycodone hydrochloride injection, and other products; anti-AIDS products comprising kedu/zidovudine tablets, kedu/zidovudine capsules, efavirenz tablets, zidolamid bivudine tablets, and other products; and in vitro biological diagnostic reagent products, such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. In addition, it offers general health products, including vitamin C powder, effervescent tablets, chewable tablets, solid drinks, glycosaminoglycan chondroitin sulfate collagen D3 calcium capsules, protein powder, probiotic powder, and other products. Further, the company provides Zhengchangsheng aluminum carbonate magnesium chewable tablets; Zhenxiwei compound proglumide and cimetidine tablets; amlodipine maleate; compound licorice series; narcotine syrup; Kefei, a compound codeine phosphate syrup; Xiaoke, a citronix tablets; acetaminophen tablets, pain-relieving tablets; metronidazole tablets; tinidazole tablets; paracetamol tablets; and other products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
Over the past 7 days, the market has risen 1.8% with the Industrials sector contributing the most to the gain. The market is up 24% over the last 12 months. Earnings are forecast to grow by 27% annually. Market details ›